Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG | Income Statement

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,319.00
2,591.00
4,321.00
19,033.00
22,943.00
31,657
Cost of Goods Sold (COGS) incl. D&A
193.00
274.00
1,481.00
4,108.00
4,447.00
5,405
Gross Income
1,126.00
2,317.00
2,840.00
14,925.00
18,496.00
26,252
SG&A Expense
8,146.00
10,776.00
26,943.00
48,306.00
69,156.00
77,786
EBIT
7,020.00
-
23,156.00
33,381.00
50,660.00
51,534
Unusual Expense
981.00
-
26,157.00
-
2,540.00
2,295
Non Operating Income/Expense
295.00
505.00
69.00
182.00
416.00
217
Interest Expense
21.00
-
-
-
3,843.00
4,501
Pretax Income
5,760.00
7,950.00
2,934.00
33,194.00
51,275.00
53,864
Income Tax
5.00
2.00
3,015.00
2,221.00
257.00
322
Consolidated Net Income
5,755.00
7,952.00
5,949.00
35,415.00
51,532.00
54,186
Net Income
5,755.00
7,952.00
5,949.00
35,415.00
51,532.00
54,186
Net Income After Extraordinaries
5,755.00
7,952.00
5,949.00
35,415.00
51,532.00
54,186
Net Income Available to Common
5,755.00
7,952.00
5,949.00
35,415.00
51,532.00
54,186
EPS (Basic)
1.55
1.69
1.11
5.65
8.22
7.86
Basic Shares Outstanding
3,708.30
4,704.00
5,343.10
6,273.50
6,269.80
6,891.60
EPS (Diluted)
1.55
1.69
1.08
5.65
8.22
7.86
Diluted Shares Outstanding
3,708.30
4,704.00
5,483.50
6,273.50
6,269.80
6,891.60
EBITDA
6,967.00
8,384.00
22,034.00
30,117.00
47,278.00
47,792
Other Operating Expense
-
-
947.00
-
-
-
Non-Operating Interest Income
5.00
4.00
2.00
5.00
272.00
93

About Santhera Pharmaceuticals Holding

View Profile
Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.